Hillrom (NYSE:HRC) shares dipped slightly despite second-quarter results that beat the consensus forecast. The Chicago-based company posted profits of $87.1 million, or $1.30 per share, on sales of $762 million for the three months ended March 31, 2021, for an 85.7% bottom-line gain on sales growth of 5.4%. Adjusted to exclude one-time items, earnings per […]
Hillrom
MedTech 100 roundup: Industry sees largest fall since October
The medtech industry’s hot start to 2021 has finally come to a full halt after stocks fell harder than they had in more than four months. MassDevice‘s MedTech 100 index ended the week (March 5) at 103.3 points, marking a -3.1% dip from the 106.65-point mark set one week before (Feb. 26). In less than a […]
DTW Podcast: Can AI, advanced imaging and robotics ‘democratize’ surgery?
A new generation of digital surgery systems will level surgeons’ playing field — giving them artificial intelligence, robotic tools, and other assistive technologies. In three interviews in this week’s DeviceTalks Weekly Podcast, leaders from Asensus, ActivSurgical and Memic explain how their systems will improve surgeon performance, reduce errors, and deliver the “democratization” of surgical robotics. […]
Hillrom execs change their minds on BardyDx acquisition
Hillrom (NYSE:HRC) says closing conditions have not been met when it comes to the company’s previously planned $375 million acquisition of Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch. In response, BardyDx has sued Hillrom in the Delaware Court of Chancery, asking the court to order the merger to proceed because Hillrom’s argument […]
Hillrom has a serious overhead lift recall
FDA has designated Hillrom’s recall of its Liko Multirall 200 overhead lift as Class I, its most serious level. Hillrom (NYSE:HRC) initiated the recall on Dec. 18, 2020. It involves 11,600 devices, which are used to move patients from room to room. The recalled devices have a risk of the Q-link strap locks not attaching to […]
These 5 medtech companies made it into the top 200 of Forbes’ best places to work list
Johnson & Johnson, Steris, Philips, Fujifilm Holdings and Boston Scientific were recently named among Forbes’ best large employers in America, based on feedback from their employees. Forbes partnered with a market research firm to survey 50,000 Americans working for businesses with at least 1,000 employees. Survey participants were asked to rate their willingness to recommend their employer […]
Hillrom beats The Street in Q1, raises 2021 guidance
Hillrom (NYSE:HRC) shares remain up after Street-beating first-quarter results and a raised 2021 guidance. The Chicago-based company posted profits of $58 million, or 88¢ per share, on sales of $741.1 million for the three months ended Dec. 31, 2020, for a 47.7% bottom-line gain on sales growth of 8.2%. Adjusted to exclude one-time items, earnings […]
EarlySense sells contact-free monitoring system to Hillrom
EarlySense today said it has sold its contact-free continuous monitoring technology to Hillrom. Through the deal, EarlySense will receive licensing for all intellectual property and technology sold to Hillrom and $30 million in cash with potential payments based on certain commercial milestone achievements. EarlySense will also receive a portion of Hillrom’s equity investment in the […]
MedTech 100 roundup: Another peak for the industry
Medtech stocks have been on the rise in 2021, and the past week saw the trend continue with yet another all-time best mark. MassDevice‘s MedTech 100 index reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 […]
Hillrom to buy Bardy Diagnostics for $375M
Hillrom (NYSE:HRC) has agreed to spend $375 million to acquire Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch. Analysts at Baird described the CAM patch as a long-term Holter wearable biosensor. Hillrom said in a news release out today that the BardyDx purchase complements Hillrom’s present cardiology portfolio of cardiac stress exercise, Holter and […]
Hillrom beats The Street in Q4
Hillrom (NYSE:HRC) today reported fourth-quarter results that exceeded the consensus forecast on Wall Street, and company officials foresee stronger-than-expected earnings in the coming months. The Chicago-based maker of hospital beds, patient monitoring and diagnostic equipment and more reported profits of $42.4 million, or 63¢ per share, on sales of $705.3 million for the three months ended […]
